🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Dr Brian Koffman
ECLLA is deeply grateful to Dr Brian Koffman, MDCM (retired) MS Ed, Co-Founder and Chief Medical Officer Emeritus, CLL Society Inc., and member of European CLL Association – ECLLA Medical Advisory Board, for bringing both professional expertise and lived...
ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026
The ECLLA team proudly participated in the 31st Congress of the European Hematology Association (EHA 2026), held from June 11–14, 2026, in Stockholm, Sweden. As one of the world’s premier hematology events, EHA brings together leading experts, researchers,...
📍 Live from Stockholm! Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”
Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”...